Vittoria Di Bartolo

Learn More
BACKGROUND Liraglutide, a long-acting glucagon-like peptide-1 (GLP-1) analog, has several non- glycemic properties, but its effect on carotid intima-media thickness (IMT), a recognized marker of subclinical atherosclerosis, is still unknown. METHODS A prospective study of 8 months duration in 64 patients with type-2 diabetes and no prior history of(More)
  • 1